Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of California - San Diego
San Diego, California, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- the Feinstein Institute for Medical Research
Manhasset, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Nov 2018
- Primary completion
- 5 Aug 2025
- Completion
- 3 Feb 2026
- Last update posted
- 5 Feb 2026
- Registered enrollment
- 81
- Registry id
- NCT02633163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.